Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-02-23FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for Fluphenazine Decanoate from Fresenius Kabi USA, LLC, related to its continued use as a long-…
-
FDA approval · 2017-02-23FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
FDA approval · 2017-02-23FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for thioridazine hydrochloride submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2017-02-23FDA Approved: LOXAPINE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for LOXAPINE from Lannett Company, Inc., granting regulatory approval for an updated/expanded generi…
-
FDA approval · 2017-02-23FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
The FDA approved a supplemental application for Versacloz (clozapine) filed by TruPharma LLC. The action constitutes FDA approval of the sup…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-02-23FDA Approved: REXULTI — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approved a supplemental application for Rexulti (brexpiprazole) submitted by Otsuka America Pharmaceutical, Inc. The approval updates th…
-
FDA approval · 2017-02-23FDA Approved: VRAYLAR — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for VRAYLAR (cariprazine) submitted by Allergan, Inc.
-
FDA approval · 2017-02-23FDA Approved: ARISTADA — Supplemental Application (Alkermes, Inc.)
The FDA approved a supplemental application for ARISTADA (aripiprazole lauroxil) from Alkermes, Inc., to update the product labeling.
-
FDA approval · 2017-02-23FDA Approved: PERPHENAZINE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
FDA approved Wilshire Pharmaceuticals’ supplemental application for PERPHENAZINE. The approval updates the generic's regulatory status under…
-
FDA approval · 2017-02-23FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for thioridazine hydrochloride (Chartwell RX, LLC), authorizing continued marketing of this antipsyc…
-
FDA approval · 2017-02-23FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for thioridazine hydrochloride for Chartwell RX, LLC.
-
FDA approval · 2017-02-23FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal Consta (risperidone) from Janssen Pharmaceuticals, Inc., granting changes to the produ…
-
FDA approval · 2017-02-23FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc., resulting in changes to its …
-
FDA approval · 2017-02-23FDA Approved: LOXAPINE — Supplemental Application (Elite Laboratories, Inc.)
The FDA approved a supplemental application for LOXAPINE submitted by Elite Laboratories, Inc., for this generic loxapine product. Loxapine …
-
FDA approval · 2017-02-23FDA Approved: MOLINDONE HYDROCHLORIDE — Supplemental Application (EPIC PHARMA, LLC)
The FDA approved a supplemental application for molindone hydrochloride, a generic antipsychotic, submitted by Epic Pharma, LLC.
-
FDA approval · 2017-02-23FDA Approved: INVEGA HAFYERA — Supplemental Application (Janssen Pharmaceuticals, Inc)
FDA approves Janssen's supplemental application for INVEGA HAFYERA (paliperidone palmitate), updating its labeling for schizophrenia in adul…
-
FDA approval · 2017-02-23FDA Approved: CHLORPROMAZINE HCI — Supplemental Application (Dr. Reddy's Laboratories Inc.,)
FDA approved a supplemental application for Chlorpromazine HCl by Dr. Reddy's Laboratories Inc., granting approval for a generic version of …
-
FDA approval · 2017-02-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for aripiprazole, enabling the generic version to be marketed.
-
FDA approval · 2017-02-23FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for Lannett's generic fluphenazine hydrochloride, enabling the sale of this antipsychotic as a g…
-
FDA approval · 2017-02-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application to authorize a generic aripiprazole product by Lannett Company, Inc. under ANDA204171.
-
FDA approval · 2017-02-17FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's original application for ziprasidone hydrochloride, granting a generic version of ziprasidon…
-
FDA approval · 2017-02-01FDA Approved: RISPERIDONE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for risperidone submitted by Ajanta Pharma USA Inc. The approval indicates updated labeling and pote…
-
FDA approval · 2017-02-01FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for aripiprazole (generic ARIPIPRAZOLE) from Amneal Pharmaceuticals LLC, authorizing the generic for…
-
FDA approval · 2017-01-26FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
FDA approved a supplemental application for CLOZARIL (clozapine) submitted by HLS Therapeutics (USA), Inc.
-
FDA approval · 2017-01-13FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for SAPHRIS (asenapine) filed by Allergan, Inc., indicating an update to the product's labeling/indi…